Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
DVYSR.STthis companyDevyser Diagnostics AB (publ)	SEK 64.90	-223.92×	5.35×	7.56×	49.58×	-193.5%	80.6%	4.2%	-3.4%	-2.4%	2.6%	0.4%	0.15×	-0.68×	0.78×	2.88×	0.0%	7	6.42	2	C+
BICO.STBICO Group AB (publ)	SEK 23.75	-1.36×	0.85×	0.99×	-48.97×	-130.1%	38.9%	-16.8%	-72.7%	-62.3%	-7.9%	3.7%	0.86×	-6.38×	-0.78×	1.27×	0.0%	6	-2.84	3	B-
BINV.STBioInvent International AB (publ)	SEK 2.95	-5.81×	3.47×	8.54×	-4.79×	-4108.5%	100.0%	-155.1%	-147.0%	-59.7%	-62.1%	-13.2%	0.02×	1.05×	0×	5.67×	0.0%	3	-2.93	1	C-
CARA.STCarasent AB	SEK 25.60	54.9×	2.36×	5.54×	24.49×	-133.9%	84.1%	2.7%	10.1%	4.3%	1.1%	-0.0%	0.04×	-1.47×	4.95×	1.95×	0.0%	7	6.4	3	B
EGTX.STEgetis Therapeutics AB (publ)	SEK 11.12	-5.74×	5.81×	31.51×	-5.36×	-144.1%	19.9%	-555.9%	-548.9%	-101.1%	-79.2%	-13.7%	0.27×	0.36×	-15.28×	1.05×	0.0%	5	4.55	1	C-
HUM.STHumana AB (publ)	SEK 70.90	10.66×	0.81×	0.25×	5.91×	442.5%	8.3%	4.6%	2.4%	7.6%	4.9%	26.5%	1.41×	3.64×	1.98×	0.67×	2.0%	8	1.75	—	—
Peer median	—	-1.36×	2.36×	5.54×	-4.79×	-133.9%	38.9%	-16.8%	-72.7%	-59.7%	-7.9%	-0.0%	0.27×	0.36×	0×	1.27×	0.0%	6	1.75	2	—